|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Number of the document | 2209491 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08844924.4 |
| Date of filing the European patent application | 2008-10-31 | |
| (97) | Date of publication of the European application | 2010-07-28 |
| (45) | Date of publication and mention of the grant of the patent | 2015-10-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/064821 |
| Date | 2008-10-31 |
| (87) | Number | WO 2009/056634 |
| Date | 2009-05-07 |
| (30) | Number | Date | Country code |
| 984827 P | 2007-11-02 | US |
| (72) |
CONG, Feng, US
RANGWALA, Shamina M., US
ETTENBERG, Seth, US
GUTH, Sabine, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6) |
| MOLECULES AND METHODS FOR MODULATING LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (LRP6) |